Alendronate sodium hydrate
 OpenBabel02212023462D

 18 13  0  0  0  0  0  0  0  0999 V2000
    0.9664   -0.0845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2085   -0.4103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4527    0.0832    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.1138    0.5766    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0408    0.7443    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6203    1.2378    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7019    0.2508    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5343    1.4054    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9462   -0.5780    0.0000 P   0  0  3  0  0  0  0  0  0  0  0  0
   -1.6073   -0.0845    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2850   -1.0715    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4396   -1.2391    0.0000 O   0  5  0  0  0  0  0  0  0  0  0  0
    1.6275   -0.5780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3855   -0.2522    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6248    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -2.8891    0.0000 Na  0  3  0  0  0 15  0  0  0  0  0  0
    2.2393   -2.8891    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -4.5391    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 13  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  3  9  1  0  0  0  0
  5  6  2  0  0  0  0
  5  7  1  0  0  0  0
  5  8  1  0  0  0  0
  9 10  2  0  0  0  0
  9 11  1  0  0  0  0
  9 12  1  0  0  0  0
 13 14  1  0  0  0  0
M  CHG  2  12  -1  16   1
M  END
>  <CdId>
1254

>  <Mol Weight>
325.1237

>  <Formula>
C4H18NNaO10P2

>  <ID>
T6373

>  <Name>
Alendronate sodium hydrate

>  <Synonyms>
Alendronate;MK 217;Fosamax

>  <CAS>
121268-17-5

>  <Approved status>
FDA

>  <Disease>
Metabolism

>  <Indication>
Corticosteroid-induced osteoporosis; Fracture; Male osteoporosis; Malignant hypercalcaemia; Osteitis deformans; Osteoporosis; Postmenopausal osteoporosis

>  <Pathways>
Metabolism

>  <Target>
Transferase inhibitor

>  <Receptor>
Farnesyl diphosphate synthase

$$$$
